Opportunity Information: Apply for CDC RGA GH13 1316

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Implementation of Integrated HIV/AIDS Treatment, Care and Prevention Programs in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
  • This funding opportunity was created on Jan 29, 2013 and posted on Jan 29, 2013.
  • Applicants must submit their applications by Apr 15, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $25,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $5,000,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • The Ministry of Health (MOH) is the only appropriate and qualified organization to conduct a specific set of activities supportive of the CDC Global AIDS Program s technical assistance to Mozambique for the following reasons (1) the MOH is uniquely positioned, in terms of legal authority, ability, and credibility among Mozambique citizens, to collect crucial data on HIV/AIDS as well as to provide care to HIV infected patients (2) the MOH in Mozambique is mandated to perform the activities necessary for the control of epidemic, including HIV/AIDS (3) private health care services are virtually nonexistent, however, the MOH already has an established network of health care facilities of varying capacity throughout Mozambique.
Apply for CDC RGA GH13 1316

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

This grant opportunity, titled "Implementation of Integrated HIV/AIDS Treatment, Care and Prevention Programs in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief," is a Centers for Disease Control and Prevention (CDC) funding announcement designed to strengthen Mozambique's national response to HIV/AIDS through a comprehensive, integrated approach. The overall intent is to support a coordinated package of HIV prevention, treatment, and care services, while also building the underlying systems needed to run those services effectively and measure their impact. The award is structured as a cooperative agreement, which typically means the CDC anticipates substantial involvement in program oversight, technical guidance, or collaboration as the activities are carried out, rather than functioning purely as a hands-off funder.

The program emphasizes integration across clinical services, community-based programming, and public health infrastructure. On the service delivery side, it supports core HIV interventions such as counseling and testing, prevention of mother-to-child transmission (PMTCT), and both adult and pediatric HIV care and treatment. It also highlights "positive prevention," meaning prevention strategies targeted to people living with HIV to reduce onward transmission and improve health outcomes. Another key focus is prevention among "most at risk populations," indicating attention to groups with elevated HIV risk and the need for targeted, tailored prevention strategies that are grounded in local epidemiology and feasible within Mozambique's health system and legal context.

In addition to classic HIV program components, the opportunity explicitly supports related and co-morbid conditions and cross-cutting public health priorities. Tuberculosis (TB) is included, reflecting the close relationship between HIV and TB and the need for coordinated screening, diagnosis, and treatment. Sexually transmitted infections (STIs) are also part of the scope, which aligns with broader sexual health programming and the role of STIs in increasing HIV transmission risk. Cervical cancer is specifically named, which is significant because women living with HIV face higher cervical cancer risk, and integration of screening and treatment into HIV platforms is often an efficient way to expand access. The announcement also mentions improving and expanding reproductive health services in both clinical and community settings, reinforcing a more holistic model that links HIV services with family planning, maternal health, and broader sexual and reproductive healthcare.

A major portion of the proposed activities center on strengthening the systems that make large-scale HIV programming work. The announcement calls out monitoring and evaluation (M and E) and strategic information, suggesting an emphasis on data-driven management, performance tracking, and using evidence to improve program quality. It also includes establishing health information systems capable of routine HIV program monitoring and evaluation, which implies support for data collection tools, reporting workflows, database systems, and the training and supervision required to ensure data quality. Biosafety is another system-related priority, typically tied to laboratory and clinical infection prevention practices, safe handling of specimens, and protecting healthcare workers and patients.

Workforce capacity is a defined element as well, through the inclusion of human resources for health. This points to investments in staffing models, training, mentorship, supportive supervision, and potentially retention strategies, all aimed at ensuring facilities have competent personnel to deliver HIV services. The announcement also references prevention of HIV in the workplace, which can encompass occupational exposure prevention for healthcare workers as well as broader workplace education and stigma-reduction efforts in other sectors. Traditional medicine is included, reflecting Mozambique's context where traditional healers and practices may play a role in health-seeking behavior; this may involve engagement, referral linkages, or strategies to align community practices with evidence-based HIV care and prevention.

From a funding and administrative standpoint, the opportunity was posted January 29, 2013, with an application deadline of April 15, 2013, and an archive date of May 15, 2013, indicating it is a past funding round. The estimated total funding amount is $25,000,000, with an award ceiling listed as $5,000,000 and a floor of $0, and the CDC expected to make one award. The funding is categorized under Health, and it falls under CFDA number 93.067 (Global AIDS). There is no cost-sharing or matching requirement, meaning the recipient would not be required to contribute additional non-federal funds as a condition of the award.

Eligibility is effectively restricted to Mozambique's Ministry of Health (MOH). The announcement justifies this limitation by stating that the MOH is uniquely positioned to carry out the required activities because it has the legal authority and public credibility to collect critical HIV/AIDS data and provide care, it is mandated to conduct epidemic control activities (including HIV/AIDS), and private healthcare services are described as virtually nonexistent. It also notes that the MOH already operates an established nationwide network of health facilities with varying capacity, making it the only organization able to implement the specified package at scale and in alignment with national systems.

For applicants or stakeholders needing assistance accessing the full announcement, the contact listed is the CDC Procurement and Grants Office Technical Information Management team, reachable by telephone at (770) 488-2700 or by email at pgotim@cdc.gov.

Frequently Asked Questions (FAQs)

What is the title of this grant opportunity?

The opportunity is titled "Implementation of Integrated HIV/AIDS Treatment, Care and Prevention Programs in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief."

Which agency is offering this funding opportunity?

The funding announcement is offered by the Centers for Disease Control and Prevention (CDC).

What is the main goal of the program?

The intent is to strengthen Mozambique's national response to HIV/AIDS through a comprehensive, integrated approach that supports a coordinated package of HIV prevention, treatment, and care services, while also building the systems needed to deliver services effectively and measure impact.

What type of award mechanism is used (grant vs. cooperative agreement)?

This award is a cooperative agreement, which generally means the CDC anticipates substantial involvement in program oversight, technical guidance, or collaboration during implementation rather than acting as a strictly hands-off funder.

What kinds of activities and services are included in the scope?

The scope includes integrated HIV prevention, treatment, and care activities delivered across clinical services, community-based programming, and public health infrastructure, along with system-building to support and evaluate those activities.

Which core HIV service delivery components are specifically mentioned?

The announcement highlights HIV counseling and testing, prevention of mother-to-child transmission (PMTCT), and adult and pediatric HIV care and treatment.

What does "positive prevention" mean in this opportunity?

"Positive prevention" refers to prevention strategies targeted to people living with HIV, intended to reduce onward transmission and improve health outcomes.

Does the program address prevention for populations at elevated risk?

Yes. The opportunity emphasizes prevention among "most at risk populations," indicating tailored prevention strategies for groups with elevated HIV risk, grounded in local epidemiology and feasible within Mozambique's health system and legal context.

Are tuberculosis (TB) activities included?

Yes. Tuberculosis (TB) is included, reflecting the close relationship between HIV and TB and the need for coordinated screening, diagnosis, and treatment.

Are sexually transmitted infections (STIs) included in the program scope?

Yes. STIs are included as part of the scope, aligning with broader sexual health programming and the role of STIs in increasing HIV transmission risk.

Does the opportunity include cervical cancer activities?

Yes. Cervical cancer is specifically named, reflecting the higher cervical cancer risk among women living with HIV and the value of integrating screening and treatment into HIV service platforms.

Are reproductive health services part of the supported activities?

Yes. The announcement mentions improving and expanding reproductive health services in both clinical and community settings, linking HIV services with family planning, maternal health, and broader sexual and reproductive healthcare.

What system-strengthening areas are emphasized?

System-strengthening priorities include monitoring and evaluation (M and E), strategic information, establishing health information systems for routine HIV program monitoring and evaluation, and biosafety.

What is meant by "monitoring and evaluation" and "strategic information" in this context?

These terms point to data-driven management and performance tracking, using evidence to improve program quality, and building the capacity to routinely collect, report, and use HIV program data.

What does the opportunity say about health information systems?

It calls for establishing health information systems capable of routine HIV program monitoring and evaluation, implying support for data collection tools, reporting workflows, database systems, and the training and supervision needed to maintain data quality.

Why is biosafety included as a priority area?

Biosafety is typically tied to laboratory and clinical infection prevention practices, safe handling of specimens, and protecting healthcare workers and patients.

Does the opportunity address workforce needs?

Yes. Human resources for health is included, pointing to investments such as staffing models, training, mentorship, supportive supervision, and potentially retention strategies to ensure facilities have competent personnel to deliver HIV services.

Is workplace HIV prevention included?

Yes. The announcement references prevention of HIV in the workplace, which can include occupational exposure prevention for healthcare workers and broader workplace education and stigma-reduction efforts in other sectors.

How does traditional medicine relate to the program?

Traditional medicine is included to reflect Mozambique's context, where traditional healers and practices may influence health-seeking behavior; this may involve engagement, referral linkages, or strategies to align community practices with evidence-based HIV care and prevention.

When was this opportunity posted, and what were the key dates?

The opportunity was posted on January 29, 2013. The application deadline was April 15, 2013, and the archive date was May 15, 2013.

Is this an active funding opportunity?

Based on the posted date, application deadline, and archive date provided, this appears to be a past (archived) funding round.

What is the estimated total funding amount?

The estimated total funding amount is $25,000,000.

What are the award ceiling and floor?

The award ceiling is listed as $5,000,000, and the award floor is listed as $0.

How many awards did the CDC expect to make?

The CDC expected to make one award.

What is the CFDA number associated with this opportunity?

The opportunity is listed under CFDA number 93.067 (Global AIDS).

What funding category does this opportunity fall under?

The funding is categorized under Health.

Is cost sharing or matching required?

No. The announcement states there is no cost-sharing or matching requirement, meaning the recipient is not required to contribute non-federal funds as a condition of the award.

Who is eligible to apply?

Eligibility is effectively restricted to Mozambique's Ministry of Health (MOH).

Why is eligibility limited to Mozambique's Ministry of Health (MOH)?

The announcement justifies this limitation by noting that the MOH has the legal authority and public credibility to collect critical HIV/AIDS data and provide care, is mandated to conduct epidemic control activities (including HIV/AIDS), private healthcare services are described as virtually nonexistent, and the MOH already operates a nationwide network of health facilities needed to implement the package at scale and within national systems.

Who can be contacted for help accessing the full announcement?

The contact listed is the CDC Procurement and Grants Office Technical Information Management team, reachable at (770) 488-2700 or by email at pgotim@cdc.gov.

Browse more business programs for HIV and AIDS support

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Chesapeake Bay Financial Assistance Awards

Previous opportunity: Open Competition for Professional Fellows Program

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RGA GH13 1316

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RGA GH13 1316) also looked into and applied for these:

Funding Opportunity
Clinical Sites for an Undiagnosed Diseases Network (UDN) (U01) Apply for RFA RM 13 004

Funding Number: RFA RM 13 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implementation of Integrated HIV/AIDS Treatment, Care and Prevention Programs in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1316

Funding Number: CDC RFA GH13 1316
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $5,000,000
Strengthening Community Care and Support Systems and Services (SCCSSS) in Namibia Apply for SOL 673 13 000002

Funding Number: SOL 673 13 000002
Agency: South Africa USAID Pretoria
Category: Health
Funding Amount: $9,000,000
Indigenous Child Health Strong Communities, Healthy Children Apply for HHS 2013 IHS HPDP 0001

Funding Number: HHS 2013 IHS HPDP 0001
Agency: Indian Health Service
Category: Health
Funding Amount: $100,000
Providing Information System Support for Training and Implementation of National HIV Monitoring Systems in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1318

Funding Number: CDC RFA GH13 1318
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $320,000
NIA Limited Competition Renewals of, and Revisions to, Existing Cooperative agreement Awards (U01) Apply for PAR 13 097

Funding Number: PAR 13 097
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Behavioral and Serological Survey (BSS) for HIV and Syphilis among Diamond Mine Workers in Angola Apply for CDC RFA GH13 1354

Funding Number: CDC RFA GH13 1354
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $500,000
Technical Collaboration with the Peoples Republic of China (PRC) on Innovative Approaches to Increase the Effectiveness of the HIV/AIDS Response in China and Globally under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1364

Funding Number: CDC RFA GH13 1364
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $2,000,000
Disorders of Human Communication Effectiveness, Outcomes and Health Services Research (R21) Apply for PA 13 103

Funding Number: PA 13 103
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Disorders of Human Communication Effectiveness, Outcomes and Health Services Research (R01) Apply for PA 13 102

Funding Number: PA 13 102
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
High End Instrumentation Grant Program (S10) Apply for PAR 13 101

Funding Number: PAR 13 101
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Limited Competition Global Health Research and Research Training eCapacity Initiative (R25) Apply for PAR 13 107

Funding Number: PAR 13 107
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
APS for Microbicide Research, Development, and Introduction, Round 2 Apply for APS OAA 13 000001

Funding Number: APS OAA 13 000001
Agency: Agency for International Development
Category: Health
Funding Amount: $168,000,000
Affordable Care Act Health Center Controlled Networks Apply for HRSA 13 267

Funding Number: HRSA 13 267
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Maternal and Child Health (MCH) Nutrition Training Program Apply for HRSA 13 180

Funding Number: HRSA 13 180
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Genomic Centers for Infectious Diseases (U19) Apply for RFA AI 13 009

Funding Number: RFA AI 13 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
MCH Knowledge to Practice Program Apply for HRSA 13 197

Funding Number: HRSA 13 197
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Dental Reimbursement Program Apply for HRSA 13 171

Funding Number: HRSA 13 171
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
MCH Navigator Program Apply for HRSA 13 262

Funding Number: HRSA 13 262
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Grants to Expand the Use of Technology Assisted Care in Targeted Areas of Need Apply for TI 13 008

Funding Number: TI 13 008
Agency: Substance Abuse Mental Health Services Adminis.
Category: Health
Funding Amount: $280,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RGA GH13 1316", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.